These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 28747497

  • 1. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after In Vitro and In Vivo Passage.
    Phan SI, Adam CM, Chen Z, Citron M, Liang X, Espeseth AS, Wang D, He B.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28747497
    [Abstract] [Full Text] [Related]

  • 2. Parainfluenza Virus 5 Expressing Wild-Type or Prefusion Respiratory Syncytial Virus (RSV) Fusion Protein Protects Mice and Cotton Rats from RSV Challenge.
    Phan SI, Zengel JR, Wei H, Li Z, Wang D, He B.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28747496
    [Abstract] [Full Text] [Related]

  • 3. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge.
    Wang D, Phan S, DiStefano DJ, Citron MP, Callahan CL, Indrawati L, Dubey SA, Heidecker GJ, Govindarajan D, Liang X, He B, Espeseth AS.
    J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28298602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B, Munir S, Amaro-Carambot E, Surman S, Mackow N, Yang L, Buchholz UJ, Collins PL, Schaap-Nutt A.
    J Virol; 2014 Apr 01; 88(8):4237-50. PubMed ID: 24478424
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28835504
    [Abstract] [Full Text] [Related]

  • 9. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates.
    Tao T, Skiadopoulos MH, Davoodi F, Riggs JM, Collins PL, Murphy BR.
    J Virol; 2000 Jul 15; 74(14):6448-58. PubMed ID: 10864657
    [Abstract] [Full Text] [Related]

  • 10. Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backbone.
    Schmidt AC, Wenzke DR, McAuliffe JM, St Claire M, Elkins WR, Murphy BR, Collins PL.
    J Virol; 2002 Feb 15; 76(3):1089-99. PubMed ID: 11773385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N, Amaro-Carambot E, Liang B, Surman S, Lingemann M, Yang L, Collins PL, Munir S.
    J Virol; 2015 Oct 15; 89(20):10319-32. PubMed ID: 26223633
    [Abstract] [Full Text] [Related]

  • 14. Parainfluenza virus 5 (PIV5) amplifying virus-like particles expressing respiratory syncytial virus (RSV) antigens protect mice against RSV infection.
    Huertas-Díaz MC, Phan S, Elson A, Nuñez I, Wei H, Sakamoto K, He B.
    Vaccine; 2019 May 16; 37(22):2925-2934. PubMed ID: 31010715
    [Abstract] [Full Text] [Related]

  • 15. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
    Nelson CL, Tang RS, Stillman EA.
    Vaccine; 2013 Aug 12; 31(36):3756-62. PubMed ID: 23623857
    [Abstract] [Full Text] [Related]

  • 16. Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.
    Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S.
    J Virol; 2017 Aug 01; 91(15):. PubMed ID: 28539444
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.
    Wiegand MA, Gori-Savellini G, Gandolfo C, Papa G, Kaufmann C, Felder E, Ginori A, Disanto MG, Spina D, Cusi MG.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28250126
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector.
    Wiegand M, Gori-Savellini G, Martorelli B, Bossow S, Neubert WJ, Cusi MG.
    Vaccine; 2013 Aug 20; 31(37):3888-93. PubMed ID: 23831325
    [Abstract] [Full Text] [Related]

  • 20. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
    Tang RS, MacPhail M, Schickli JH, Kaur J, Robinson CL, Lawlor HA, Guzzetta JM, Spaete RR, Haller AA.
    J Virol; 2004 Oct 20; 78(20):11198-207. PubMed ID: 15452239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.